CARB-X is awarding US$1.8 million to Chembio Diagnostic Systems, Inc. to develop a rapid point-of-care test for the detection of Immunoglobulin A (IgA) antibodies to diagnose acute infection of Salmonella enterica serovar Typhi.
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
Oysters famously filter their surrounding water, but it turns out they are removing more than algae and excess nutrients. New research shows they can also reduce the spread of disease in nearby marine species, including Chesapeake Bay’s prized blue crabs.
Researchers have overcome a major obstacle that limited their ability to continuously grow human norovirus. They identified factors that restrict viral replication and developed a way to overcome them to optimize long-term viral cultivation.
Natto, a Japanese food made from soybeans fermented with the Bacillus subtilis var. natto microorganism, is rich in supersulfide molecules, which are attracting attention in the medical and nutritional fields. Researchers extensively analyzed supersulfide content in natto fermentation using various methods.
Researchers studying Plasmodium falciparum have found that the parasite relies on a brief but essential stage, nicknamed the “Crown” stage, to make sure a crucial internal structure is passed on correctly when it divides.
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.
Oysters famously filter their surrounding water, but it turns out they are removing more than algae and excess nutrients. New research shows they can also reduce the spread of disease in nearby marine species, including Chesapeake Bay’s prized blue crabs.
Researchers have overcome a major obstacle that limited their ability to continuously grow human norovirus. They identified factors that restrict viral replication and developed a way to overcome them to optimize long-term viral cultivation.
CARB-X is awarding US$1.8 million to Chembio Diagnostic Systems, Inc. to develop a rapid point-of-care test for the detection of Immunoglobulin A (IgA) antibodies to diagnose acute infection of Salmonella enterica serovar Typhi.
With the latest innovation from the team at Singer Instruments, a new standard for speed and repeatability in microbial colony pickers has been achieved through the integration of cutting edge AI technologies.
UK biotechnology company NexaBiome Life Sciences Ltd has received continued funding from Scotland’s national economic development agency, Scottish Enterprise, to accelerate its breakthrough bacteriophage technology for the treatment of diabetic foot infections (DFIs).
Researchers have developed a high‑performance coating made from peppermint essential oil that can be applied to the surfaces of many commonly used medical devices, offering a safer way to protect patients from infection and inflammation.
An international research team has developed a new yeast-based biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before. It can reduce development time for new types of cancer immunotherapy from months to days or weeks.
A surface capable of responding to chemical signals generated by microorganisms and automatically producing biocidal substances – a description of how the B-STING silica nanocomposite works. The new material acts as a nanofactory of reactive oxygen species, activating only when necessary.
Which infections have you already come into contact with? In the future, a simple blood test may be all you need to answer that question. Researchers intend to investigate the sensors the immune system uses to identify pathogens.
A new clinical trial will test a new experimental intranasal spray designed to boost immune defenses and reduce illness from respiratory viruses.
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?